P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLCA. Horne, A. Greystoke, Vicky M. Coyle et al.|Journal of Thoracic Oncology|2023Cited by 2